Revenue: The sum of all revenue fields included for a company's operating activities.
Vir Biotechnology, Inc. (VIR) had Revenue of $16.79M for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
|
Revenue |
$16.79M |
$-115.97M |
|
$0.80M |
|
$15.99M |
|
$155.80M |
|
$-139.02M |
|
$18.26M |
|
$-120.76M |
|
$-120.76M |
|
$-115.97M |
|
$-115.97M |
|
$-115.97M |
|
$-115.97M |
|
$-139.02M |
|
$-133.19M |
|
134.13M |
|
134.13M |
|
$-0.86 |
|
$-0.86 |
|
| Balance Sheet Financials | |
$1.59B |
|
$96.02M |
|
$330.83M |
|
$1.92B |
|
$175.41M |
|
-- |
|
$153.42M |
|
$328.82M |
|
$1.59B |
|
$1.55B |
|
$1.59B |
|
134.78M |
|
| Cash Flow Statement Financials | |
$-778.78M |
|
$164.63M |
|
$7.48M |
|
$867.97M |
|
$261.29M |
|
$-606.68M |
|
$111.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.05 |
|
-- |
|
-- |
|
-- |
|
-- |
|
95.25% |
|
-828.12% |
|
-828.12% |
|
-- |
|
-719.35% |
|
-690.85% |
|
$-800.36M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-7.29% |
|
-7.48% |
|
-6.04% |
|
-7.29% |
|
$11.80 |
|
$-5.97 |
|
$-5.81 |
|